Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Intro to finding retirement index funds with the lowest expense ratios and tips for evaluating ongoing costs.
27,234 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
An FDA leadership shakeup deepens as Tracy Hoeg publicly says she was fired, prompting questions about regulatory dir...
A sharp 27% drop for AppLovin stock has investors weighing risk and reward. This guide breaks down the business, the ...
ICE appoints a former GEO Group executive as acting director this week, signaling a shift in immigration enforcement ...
Trump argues against rate hikes amid a stubborn inflation backdrop, while Kevin Warsh appears set to influence a hawk...
A sharp rise in foreclosure activity points to growing distress and new chances for investors. Learn what the foreclo...
New market data indicate AI-driven productivity gains are concentrated among a small group of mega-cap firms, fueling...
A powerful winter storm has prompted an upgraded york city-area blizzard warning, raising concerns about heavy snowfa...
As crypto markets wobble, financial advisors managing $175 trillion are widening their focus beyond Bitcoin to stable...
NVIDIA is set to report quarterly results as investors wrestle with hype around AI. Analysts forecast strong growth b...
Treasury Secretary Scott Bessent pitched a bold growth plan: 3% GDP growth without higher inflation, anchored by AI-d...
Investors who have stacked some massive capital gains are weighing tax-efficient exit strategies as markets reach fre...